Clinical Trial

Statins for Treatment of Primary Intracerebral Hemorrhage

Name: Statins for Treatment of Primary Intracerebral Hemorrhage — clinical trial record (NCT07088250)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: STOP ICH

Recruiting

View on ClinicalTrials.gov →

Summary

The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.

Trial Details

NCT Number	NCT07088250
Lead Sponsor	The Second Hospital of Anhui Medical University
Conditions	Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral Haemorrhage
Enrollment	264 participants
Start Date	2023-05-06
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-28